Vaxcyte, Inc. — Director's Dealing 2025

May 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2025-05-01

Reporting Person: BRANDICOURT OLIVIER (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-01	Stock Option (right to buy)	$35.24	A	40113	Acquired	2035-05-01	Common Stock (40113)	Direct

Footnotes

F1: Option shall vest over 36 months, 1/3 of which will vest on May 1, 2026 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.